vs
Apellis Pharmaceuticals, Inc.（APLS）与RADIANT LOGISTICS, INC（RLGT）财务数据对比。点击上方公司名可切换其他公司
RADIANT LOGISTICS, INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.2倍（$232.1M vs $199.9M），RADIANT LOGISTICS, INC净利率更高（2.3% vs -29.5%，领先31.8%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -12.3%），RADIANT LOGISTICS, INC自由现金流更多（$11.6M vs $-14.3M），过去两年RADIANT LOGISTICS, INC的营收复合增速更高（12.1% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Radiant Logistics, Inc.是一家知名第三方物流服务商，提供端到端供应链解决方案、国内外货运代理、仓储及末端配送服务，核心市场覆盖北美，客户涵盖零售、制造、电商、工业等多个领域，助力企业优化物流流程、降低运营成本。
APLS vs RLGT — 直观对比
营收规模更大
RLGT
是对方的1.2倍
$199.9M
营收增速更快
APLS
高出6.3%
-12.3%
净利率更高
RLGT
高出31.8%
-29.5%
自由现金流更多
RLGT
多$25.9M
$-14.3M
两年增速更快
RLGT
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $232.1M |
| 净利润 | $-59.0M | $5.3M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 3.2% |
| 净利率 | -29.5% | 2.3% |
| 营收同比 | -5.9% | -12.3% |
| 净利润同比 | -62.2% | -18.0% |
| 每股收益（稀释后） | $-0.40 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSRLGT
| Q4 25 | $199.9M | $232.1M | ||
| Q3 25 | $458.6M | $226.7M | ||
| Q2 25 | $178.5M | $220.6M | ||
| Q1 25 | $166.8M | $214.0M | ||
| Q4 24 | $212.5M | $264.5M | ||
| Q3 24 | $196.8M | $203.6M | ||
| Q2 24 | $199.7M | $206.0M | ||
| Q1 24 | $172.3M | $184.6M |
净利润APLSRLGT
| Q4 25 | $-59.0M | $5.3M | ||
| Q3 25 | $215.7M | $1.3M | ||
| Q2 25 | $-42.2M | $4.9M | ||
| Q1 25 | $-92.2M | $2.5M | ||
| Q4 24 | $-36.4M | $6.5M | ||
| Q3 24 | $-57.4M | $3.4M | ||
| Q2 24 | $-37.7M | $4.8M | ||
| Q1 24 | $-66.4M | $-703.0K |
营业利润率APLSRLGT
| Q4 25 | -25.6% | 3.2% | ||
| Q3 25 | 48.7% | 0.9% | ||
| Q2 25 | -18.6% | 2.4% | ||
| Q1 25 | -50.0% | 1.6% | ||
| Q4 24 | -12.3% | 3.3% | ||
| Q3 24 | -24.0% | 1.9% | ||
| Q2 24 | -14.7% | 2.4% | ||
| Q1 24 | -36.0% | -0.5% |
净利率APLSRLGT
| Q4 25 | -29.5% | 2.3% | ||
| Q3 25 | 47.0% | 0.6% | ||
| Q2 25 | -23.6% | 2.2% | ||
| Q1 25 | -55.3% | 1.2% | ||
| Q4 24 | -17.1% | 2.4% | ||
| Q3 24 | -29.2% | 1.7% | ||
| Q2 24 | -18.9% | 2.3% | ||
| Q1 24 | -38.5% | -0.4% |
每股收益（稀释后）APLSRLGT
| Q4 25 | $-0.40 | $0.11 | ||
| Q3 25 | $1.67 | $0.03 | ||
| Q2 25 | $-0.33 | $0.10 | ||
| Q1 25 | $-0.74 | $0.05 | ||
| Q4 24 | $-0.30 | $0.13 | ||
| Q3 24 | $-0.46 | $0.07 | ||
| Q2 24 | $-0.30 | $0.11 | ||
| Q1 24 | $-0.54 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $31.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $229.8M |
| 总资产 | $1.1B | $439.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSRLGT
| Q4 25 | $466.2M | $31.9M | ||
| Q3 25 | $479.2M | $28.1M | ||
| Q2 25 | $370.0M | $22.9M | ||
| Q1 25 | $358.4M | $19.0M | ||
| Q4 24 | $411.3M | $19.9M | ||
| Q3 24 | $396.9M | $10.4M | ||
| Q2 24 | $360.1M | $24.9M | ||
| Q1 24 | $325.9M | $31.2M |
总债务APLSRLGT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSRLGT
| Q4 25 | $370.1M | $229.8M | ||
| Q3 25 | $401.2M | $225.7M | ||
| Q2 25 | $156.3M | $226.0M | ||
| Q1 25 | $164.2M | $218.2M | ||
| Q4 24 | $228.5M | $214.4M | ||
| Q3 24 | $237.1M | $212.4M | ||
| Q2 24 | $264.3M | $209.4M | ||
| Q1 24 | $266.7M | $206.0M |
总资产APLSRLGT
| Q4 25 | $1.1B | $439.4M | ||
| Q3 25 | $1.1B | $445.3M | ||
| Q2 25 | $821.4M | $426.8M | ||
| Q1 25 | $807.3M | $414.5M | ||
| Q4 24 | $885.1M | $386.8M | ||
| Q3 24 | $901.9M | $375.3M | ||
| Q2 24 | $904.5M | $371.2M | ||
| Q1 24 | $831.9M | $364.0M |
负债/权益比APLSRLGT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $12.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $11.6M |
| 自由现金流率自由现金流/营收 | -7.1% | 5.0% |
| 资本支出强度资本支出/营收 | 0.1% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 2.33× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $8.5M |
8季度趋势，按日历期对齐
经营现金流APLSRLGT
| Q4 25 | $-14.2M | $12.4M | ||
| Q3 25 | $108.5M | $2.5M | ||
| Q2 25 | $4.4M | $3.1M | ||
| Q1 25 | $-53.4M | $-5.7M | ||
| Q4 24 | $19.4M | $15.7M | ||
| Q3 24 | $34.1M | $205.0K | ||
| Q2 24 | $-8.3M | $1.3M | ||
| Q1 24 | $-133.0M | $3.9M |
自由现金流APLSRLGT
| Q4 25 | $-14.3M | $11.6M | ||
| Q3 25 | $108.3M | $977.0K | ||
| Q2 25 | $4.4M | $2.2M | ||
| Q1 25 | $-53.4M | $-6.4M | ||
| Q4 24 | $19.3M | $14.1M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | $-8.4M | $-185.0K | ||
| Q1 24 | $-133.3M | $1.8M |
自由现金流率APLSRLGT
| Q4 25 | -7.1% | 5.0% | ||
| Q3 25 | 23.6% | 0.4% | ||
| Q2 25 | 2.5% | 1.0% | ||
| Q1 25 | -32.0% | -3.0% | ||
| Q4 24 | 9.1% | 5.3% | ||
| Q3 24 | — | -0.9% | ||
| Q2 24 | -4.2% | -0.1% | ||
| Q1 24 | -77.3% | 1.0% |
资本支出强度APLSRLGT
| Q4 25 | 0.1% | 0.3% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | 0.0% | 0.7% | ||
| Q1 24 | 0.2% | 1.2% |
现金转化率APLSRLGT
| Q4 25 | — | 2.33× | ||
| Q3 25 | 0.50× | 1.90× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | -2.26× | ||
| Q4 24 | — | 2.43× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.26× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
RLGT
| Transferred Over Time | $201.2M | 87% |
| Other | $25.0M | 11% |
| Value Added Services | $4.2M | 2% |
| Transferred At Point In Time | $1.8M | 1% |
